Study of Dexycu in Treating Intraocular Inflammation

NCT06429306 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Cataract

Interventions

DRUG: Dexycu
DRUG: Placebo

Sponsor

Ocumension Therapeutics (Shanghai) Co., Ltd